Deferred Income Tax Expense (Benefit) of COLLEGIUM PHARMACEUTICAL, INC from 30 Sep 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
COLLEGIUM PHARMACEUTICAL, INC quarterly and annual Deferred Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2019 to 31 Mar 2025.
  • COLLEGIUM PHARMACEUTICAL, INC Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $539,000, a 88% increase year-over-year.
  • COLLEGIUM PHARMACEUTICAL, INC annual Deferred Income Tax Expense (Benefit) for 2024 was $26,814,000, a 1145% decline from 2023.
  • COLLEGIUM PHARMACEUTICAL, INC annual Deferred Income Tax Expense (Benefit) for 2023 was $2,153,000, a 74% increase from 2022.
  • COLLEGIUM PHARMACEUTICAL, INC annual Deferred Income Tax Expense (Benefit) for 2022 was $8,391,000, a 89% increase from 2021.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

COLLEGIUM PHARMACEUTICAL, INC Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $539,000 +$3,873,000 +88% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $4,412,000 -$4,366,000 -9491% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $46,000 +$5,992,000 +99% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $6,038,000 -$6,038,000 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q2 2021 $62,649,000 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 $0 $0 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q3 2019 $0 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3

COLLEGIUM PHARMACEUTICAL, INC Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $26,814,000 -$24,661,000 -1145% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $2,153,000 +$6,238,000 +74% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $8,391,000 +$69,651,000 +89% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $78,042,000 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.